The phlda3 gene encodes a small, 127-amino acid protein with only a PH domain, and is involved in tumor suppression, proliferation of islet b-cells, insulin secretion, glucose tolerance, and liver injury. However, the role of phlda3 in vascular development is unknown. Here, we show that phlda3 overexpression decreases the expression levels of hemangioblast markers scl, fli1, and etsrp and intersegmental vessel (ISV) markers flk1 and cdh5, and disrupts ISV development in tg(flk1:GFP) and tg(fli1:GFP) zebrafish. Moreover, phlda3 overexpression inhibits the activation of protein kinase B (AKT) in zebrafish embryos, and the developmental defects of ISVs by phlda3 overexpression were reversed by the expression of a constitutively active form of AKT. These data suggest that phlda3 is a negative regulator of hemangioblast specification and ISV development via AKT signaling.
Introduction
Hemangioblasts are multipotent precursor cells that are differentiated from the mesoderm, and can further differentiate into both hematopoietic and endothelial cells [1, 2] . The differentiation of hemangioblasts is regulated by many transcription factors, including scl/tal1 [3] [4] [5] , fli1, and etsrp [6] [7] [8] [9] . The differentiation of Abbreviations AGGF1, angiogenic factor with G-patch and FHA domains 1 or angiogenic factor 1; AKT, protein kinase B; hpf, hours postfertilization; HSCs, hematopoietic stem cells; ISVs, intersegmental vessels; MOs, morpholinos; PHLDA3, pleckstrin homology-like domain, family A, member 3. hematopoietic cells (hematopoiesis) in zebrafish includes either primitive hematopoiesis or definitive hematopoiesis [10] [11] [12] . Primitive hematopoiesis can be regulated and marked by two early transcription factors gata1 [13, 14] and pu.1 [15] [16] [17] . Definitive hematopoiesis is regulated by two critical transcription factors, c-myb [18] and runx1 [19] , to generate hematopoietic stem cells (HSCs), which are subsequently differentiated into blood cells with erythroid, myeloid, and lymphoid lineages. In the differentiation of endothelial cells, hemangioblasts are first differentiated into angioblasts, which later develop into vascular endothelial cells, resulting in the development of the primary vascular plexus (de novo formation of vessels; vasculogenesis) [20] . Dramatic expansion of the vascular plexus leads to the development of capillaries, arteries, and veins (angiogenesis) [1] .
Together with Qian et al. [21] , we cloned the novel human gene IPL while searching for the long QT syndrome gene on chromosome 11p15 (later referred to as PHLDA2) through cDNA selection by using a bacterial artificial chromosome at the 11p15.1 chromosomal region. The IPL protein showed a high degree of homology to the TDAG51 protein, later referred to as PHLDA1 [21] . The human PHLDA3 gene is the third member of this family of genes and encodes a PH domain-only protein [22] . The PHLDA3 protein was shown to block the activation of protein kinase B (AKT) by competing with the PH domain of AKT for the binding of lipids on the cellular membrane in tumor cell lines [22] . Knockout mice deficient in PHLDA3 demonstrated islet hyperplasia, enhanced proliferation of b-cells and insulin secretion, and improved glucose tolerance via increased AKT activation [23] . PHLDA3 blocked the generation of induced pluripotent stem cells by activating the AKT-GSK3b pathway [24] . Moreover, PHLDA3 overexpression was shown to enhance liver injury by inhibiting AKT [25] . However, the role of PHLDA3 in vascular development is unknown. Here, we used the zebrafish system to characterize the role of phlda3 in the specification of hemangioblasts, vascular development, primitive hematopoiesis, and definitive hematopoiesis. We show that phlda3 is involved in the specification of hemangioblasts and development of intersegmental vessels (ISVs) by regulating the AKT signaling pathway, but it does not play a role in hematopoiesis.
Results

Molecular cloning and expression profile of zebrafish phlda3 gene
Zebrafish phlda3 is located on chromosome 23 and encodes a PH domain-only protein with 127 amino acids. The protein sequence of zebrafish PHLDA3 protein (RefSeq peptide: NP_001002455) shows a high degree of homology to the human PHLDA3 protein (NP_036528) (52% identity, 69% homology) and mouse PHLDA3 protein (NP_038778) (52% identity, 69% homology) (Fig. 1A,B) .
We determined the expression pattern of phlda3 during zebrafish embryogenesis using whole-mount in situ hybridization. The expression of phlda3 was detected in two-cell stage embryos (Fig. 1C,I ) and four-cell stage embryos (Fig. 1C,II) , which suggests that phlda3 is maternally expressed. At the 2.5 h postfertilization (hpf) stage (the beginning of blastula stage), phlda3 was localized in the blastomeres (Fig. 1C,III) . At the 6 hpf stage and 12 hpf stage, phlda3 was expressed ubiquitously in embryos (Fig. 1C,IV,V) . At 24 hpf, phlda3 expression appeared to be restricted to the head region and dorsal aorta (Fig. 1C, VI arrows) . By 48 hpf, the phlda3 mRNA was predominantly expressed in the head and fin bud (Fig. 1C , VII arrows).
phlda3 regulates specification of hemangioblasts
Hemangioblasts are developed from the mesoderm during early embryogenesis [26, 27] . They are multipotent progenitor cells that can differentiate into both hematopoietic and endothelial cells. Transcription factor genes scl, fli1 and etsrp are markers for hemangioblasts [4, 5, 7, 8] . To investigate the role of phlda3 in the specification of hemangioblasts, vascular development, and hematopoiesis, we studied the effects of overexpression of phlda3. We amplified the full-length zebrafish phlda3 (RefSeqDNA: NM_001002455) by RT-PCR analysis and cloned it into an expression vector to generate phlda3 mRNA. We injected one-cell stage embryos with either control mCherry mRNA or phlda3 mRNA. At 12 hpf, we collected the embryos and performed whole-mount in situ hybridization with antisense probes for scl, fli1, and etsrp. Whole-mount in situ hybridization data showed that the expression levels of scl, fli1, and etsrp were markedly reduced in embryos with an overexpression of phlda3 as compared to control embryos injected with mCherry mRNA (Fig. 2) . These data suggest that an overexpression of phlda3 disrupts the specification of hemangioblasts.
phlda3 is involved in the regulation of vascular development in zebrafish Since phlda3 is involved in the specification of hemangioblasts, and hemangioblasts are differentiated into either vascular endothelial cells or hematopoietic cells, we investigated whether phlda3 affects vascular development. We injected phlda3 mRNA into one-cell stage embryos to overexpress phlda3, and then we performed whole-mount in situ hybridization with antisense probes for flt4, dab2, and notch3 at 28 hpf and for flk1 and cdh5 at 24 hpf. flt4 and dab2 are markers of the posterior cardinal vein (PCV) and notch3 is a marker of the dorsal aorta (DA) [27] [28] [29] . flk1 and cdh5 are markers of ISVs, which connect the dorsal aorta to the dorsal longitudinal anastomotic vessels [30, 31] . The whole-mount in situ hybridization data showed 
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The FEBS Journal 285 (2018) 4071-4081 ª 2018 Federation of European Biochemical Societies that compared with uninjected embryos or embryos injected with control mCherry mRNA, embryos injected with phlda3 mRNA displayed abnormal development of ISVs (incompletely developed ISVs sprouting from DA) (Fig. 3A , VII-XI, arrows). However, the overexpression of phlda3 did not affect the development of the DA or PCV (Fig. 3A, I -VI).
We also injected mCherry mRNA or phlda3 mRNA into tg(flk1:GFP) and tg(fli1:GFP) embryos to observe the development of ISVs at 24 hpf. The data showed that the overexpression of phlda3 mRNA inhibited the normal development of ISVs compared to uninjected embryos or embryos injected with control mCherry mRNA (Fig. 3B) . Taken together, these data phlda3 is not involved in either primitive or definitive hematopoiesis Hematopoiesis in zebrafish includes two successive processes: primitive hematopoiesis and definitive hematopoiesis [10] [11] [12] . The two genes gata1 [13, 14] and pu.1 [15] [16] [17] encode two early transcription factors that regulate primitive hematopoiesis. They are markers for erythroid progenitors and myeloid progenitors, respectively. The other two genes, c-myb [18] and runx1 [19] , are involved in definitive hematopoiesis to generate HSCs that further differentiate into erythroid, myeloid, and lymphoid cells. We overexpressed phlda3 with an injection of phlda3 mRNA into embryos and performed whole-mount in situ hybridization using antisense probes for gata1, pu.1, c-myb, and runx1. Whole-mount in situ hybridization did not detect apparent differences in the expression levels of primitive and definitive hematopoiesis markers (gata1, pu.1, c-myb, and runx1) between control embryos (mCherry mRNA) and embryos with an overexpression of phlda3 (Fig. 4A-H) . These data suggest that phlda3 is not involved in the regulation of either primitive or definitive hematopoiesis during zebrafish embryogenesis.
AKT rescues the developmental defects of ISVs induced by overexpression of phlda3
In 2009, Kawase et al. showed that PHLDA3 blocks the activation of AKT [22] . Therefore, we investigated a possible molecular mechanism by which the overexpression of phlda3 regulates development of ISVs via its effect on the activation of AKT. We injected either control mCherry mRNA or phlda3 mRNA into zebrafish embryos and collected embryos at 24 hpf to prepare protein extracts for western blot analysis with an anti-phosphorylated AKT antibody or a control antibody against total AKT [28] . Western blot analysis showed that compared with uninjected embryos or embryos injected with control mCherry mRNA, embryos injected with phlda3 mRNA exhibited a significantly reduced level of phosphorylated AKT (Fig. 5A ). These data suggest that the overexpression of phlda3 mRNA inhibits the activation of AKT in zebrafish.
To determine whether reduced AKT activation by the overexpression of phlda3 is critical to the disrupted ISV development, we coinjected phlda3 mRNA and mRNA for a constitutively active form of AKT1 (human myristoylated-AKT1) into one-cell embryos and performed whole-mount in situ hybridization for flk1 with 24 hpf embryos [28] . As shown in Fig. 5B , compared with uninjected embryos or embryos injected with control mCherry mRNA, embryos an injection of phlda3 mRNA showed dramatically inhibited development of ISVs. However, the effect was abolished by the overexpression of the constitutive active form of human myristoylated-AKT. These data suggest that an overexpression of phlda3 inhibits ISV development by blocking the activation of AKT.
Discussion
Hemangioblasts are bipotent precursor cells that can generate both endothelial cells (vascular differentiation and development) and blood cells. In this study, we showed that the overexpression of phlda3 impaired the specification of hemangioblasts, as demonstrated by the reduced expression levels of hemangioblasts markers scl, fli1, and etsrp (Fig. 2) . With regard to vascular development, an overexpression of phlda3 inhibited the development of ISVs (reduced signal for ISVs markers flk1and cdh5) (Fig. 3A) . Furthermore, compared to uninjected embryos or embryos injected with mCherry mRNA, tg(flk1:GFP), and tg(fli:GFP) transgenic embryos injected with phlda3 mRNA showed impaired development of ISVs (Fig. 3B) . However, phlda3 overexpression had no effect on expression of the venous markers flt4 and dab2 (Fig. 3A) . Moreover, overexpression of phlda3 did not affect expression levels of primitive and definitive hematopoiesis markers gata1, pu.1, c-myb, and runx1 (Fig. 4) . These data reveal a novel role of phlda3 in the specification of hemangioblasts and development of ISVs.
The molecular mechanism for the differentiation of hemangioblasts from the mesoderm is largely unknown. We previously reported that angiogenic factor with G-patch and FHA domains 1 or angiogenic factor 1 (aggf1), a gene encoding an angiogenic factor essential for embryogenesis, is one of the earliest regulators involved in the differentiation of hemangioblasts [28] . Consequently, the knockdown of aggf1 expression had profound effects on the development of both ISVs and veins, primitive hematopoiesis, and definitive hematopoiesis [21, 29] . Although both aggf1 and phlda3 are involved in the differentiation of hemangioblasts, their effects on vascular development and hematopoiesis are clearly different. Specifically, phlda3 only affected the development of ISVs, and it did not have any overt effects on the development of veins, primitive or definitive hematopoiesis (Figs 3 and 4) . The data may suggest that hemangioblasts comprise multiple heterogeneous populations of cells. Some hemangioblasts can differentiate into vascular cells, whereas other hemangioblasts differentiate into hematopoietic cells. phlda3 may play a role in the differentiation of hemangioblasts targeted for vascular development and not hematopoiesis, thus its overexpression affects the development of ISVs, but not the differentiation of blood cells.
The PHLDA3 protein was found to block the activation of AKT signaling in various tumor cells [22] and b-cells [23] . Consistent with this, one molecular mechanism in which the overexpression of phlda3 impairs the development of ISVs is the inhibition of the AKT signaling pathway as shown in Fig. 5A [22] . Moreover, a constitutively active form of AKT successfully reversed the impaired ISV development by the overexpression of phlda3 (Fig. 5B) . We previously reported that a) a knockdown of aggf1 expression inhibited vascular development by blocking AKT activation and b) a constitutively active form of AKT successfully rescued the impaired vascular development via knockdown of aggf1 expression [28] . Therefore, both phlda3 and aggf1 regulate hemangioblast specification and ISV development via the AKT signaling pathway; however, phlda3 acts as a negative regulator whereas aggf1 acts as a positive regulator of AKT activation. The effects of overexpression of phlda3 on the development of primitive and definitive hematopoiesis in zebrafish. Zebrafish embryos at the one-cell stage were injected with either mCherry mRNA (110 pg; A, C, E, G) or phlda3 mRNA (110 pg; B, D, F, H), and used for wholemount in situ hybridization with the primitive hematopoiesis probes gata1 (A, B) and pu.1 (C, D), and definitive hematopoiesis probes c-myb (E, F) and runx1 (G, H), at 28 hpf. The expression levels of gata1, pu.1, c-myb, and runx1 were not affected by injection of phlda3 mRNA. Scale bar, 200 lm.
Despite the marked effects of the overexpression of phlda3 on the specification of hemangioblasts and development of ISVs, we did not observe any effects with a phlda3 morpholino oligomer (MO) (data not shown). Moreover, we found that the phlda3 MO failed to rescue the effects of aggf1 MO on ISVs (data not shown). One possible explanation for the lack of effect for the phlda3 MO is that the knockdown of The images for Western blotting were quantified and the fold change in phosphorylated AKT (P-AKT) over the control total AKT was plotted on the right. An unpaired Student's t-test was used to compare the means of two different groups. The data were shown as means AE SD from four independent experiments. A P-value of ≤ 0.05 was defined to be statistically significant. (B) Injection of human myristoylated-AKT mRNA can rescue the developmental defects of ISVs (flk1 signal) in embryos injected with phlda3 mRNA. Zebrafish embryos at the one-cell stage were injected with 200 pg of mCherry mRNA (II), 100 pg of mCherry mRNA plus 100 pg of human myristoylated-AKT mRNA (III), 100 pg of phlda3 mRNA (IV), or 100 pg of phlda3 mRNA plus 100 pg of human myristoylated-AKT mRNA (V), and then used for whole-mount in situ hybridization with ISVs probe flk1 at 24 hpf. Scale bar, 200 lm.
phlda3 expression with MO is expected to enhance the development of ISVs and specification of hemangioblasts, but such great enhancements above a normal level may be difficult to achieve. Alternatively, the effect of phlda3 expression knockdown may be masked by the activity of redundant genes or genes with similar functions, such as phlda1 and phlda2 [32] [33] [34] [35] . Future studies with a knockdown of all three phlda1-3 genes may further validate the role of phlda3 in the specification of hemangioblasts and development of ISVs.
In conclusion, our observations suggest that similar to aggf1, phlda3 plays an important role in the specification of hemangioblasts and regulation of development of ISVs via the AKT signaling pathway. However, phlda3 differs from aggf1 in that it may not be involved in the specification of veins and regulation of primitive and definitive hematopoiesis.
Materials and methods
Zebrafish strain and care
Wild-type AB zebrafish strain tg(flk1:EGFP) (bought from China Zebrafish Resource Centre) and tg(fli1a:EGFP) (kindly provided by Jingxia Liu from Huazhong Agricultural University) were used in the study. Zebrafish and their embryos were raised at 28.5°C using standard protocols, as described previously [36] , and collected at different stages for subsequent analysis [37, 38] . The study was approved by the ethics committee of Huazhong University of Science and Technology.
Preparation and microinjection of mRNA samples
The full-length coding sequence for zebrafish phlda3 gene was PCR-amplified from embryonic cDNA samples using two PCR primers (Forward Primer: 5 0 -CGCGG-ATCCGCCATGAACCAGTGTAAAGTAAT-3 0 ; Reverse Primer:
. Then, the PCR product was subcloned into the pCS 2+ vector, resulting in plasmid phlda3-pCS 2+ . The plasmid mCherry-pSP64 (negative control) and human myristoylated-AKT-pSP64 (myrAKT-pSP64) were described previously by us [28] .
The phlda3-pCS 2+ , mCherry-pSP64, and myrAKTpSP64 plasmids were linearized by restriction digestion and used for the generation of phlda3, mCherry, and myrAKT mRNA samples by in vitro transcription with SP6 RNA polymerase from the mMESSAGE mMACHINE kit (Ambion, Austin, TX). Capped full-length mRNA samples were injected into the zebrafish embryos (one-cell stage) using a pneumatic picopump as described by Hyatt et al. [39] . The embryos were then maintained and collected at different developmental stages for the subsequent experiments.
Synthesis of antisense RNA probes for wholemount in situ hybridization
To develop a probe for whole-mount in situ hybridization for phlda3, we used RT-PCR analysis to amplify a fragment specific for phlda3 with a forward primer (5 0 -TGGAGTATAAACGGGGTCTG-3 0 ) and a reverse primer (5 0 -GCAAAGTGAGGAGTGGAATC-3 0 ). The PCR fragment was subcloned into the pGEM-T easy vector, generating the phlda3-pGEM-T easy plasmid. The plasmids for making antisense RNA probes for scl, fli1, etsrp, gata1, pu.1, c-myb, runx1, flt4, dab2, notch3, flk1, and cdh5 were described previously by us [28, 40] .
Each plasmid was linearized by restriction digestion and used for making antisense RNA probes for whole-mount in situ hybridization using either T7 or SP6 polymerase (Promega, Madison, WI, USA) in the presence of DIGlabeled nucleotides (Roche, Mannheim, Germany).
Whole-mount in situ hybridization was performed using standard protocols as described by Thisse et al. [41] . The hybridization signals were detected using antidigoxigenin-AP (Roche) and staining with BCIP/NBT (Promega) as previously described [28, 36, 37, 40, 42] .
Western blot analysis
Protein extracts from 24 hpf stage zebrafish embryos (n = 80) were prepared as previously described [28] , separated by 10% SDS/PAGE, and then transferred to PVDF membranes. The membranes were probed with either an anti-phosphorylated-AKT (Ser473) antibody (Phospho-Akt (Ser473) (D9E) XP Ò Rabbit mAb #4060) (1 : 1000) or an anti-AKT antibody (Akt Antibody #9272) (1 : 1000) from Cell Signaling Technology (Danvers, MA, USA). Then, the membranes were incubated with a goat anti-rabbit HRPconjugated secondary antibody (1 : 20 000) (Merck Millipore, Burlington, MA, USA). Signals were detected by incubation with a SuperSignal West Pico Chemiluminescent Substrate (Thermo, Waltham, MA, USA) and ChemiDoc XRS (Bio-Rad, Hercules, CA, USA).
